[Our] practical experiences can be immensely valuable for global south countries struggling to provide similar services
In Conversation
Indian firms are supplying quality generic medicines which conform to global standards, and which bring down the high costs of medicines across the world. These high…
The government's acknowledgment of issues like policies, pricing, and intellectual property protection signals a crucial shift... fostering innovation requires incentivization... The focus should be on fostering…
If, as looks likely, more medicines will come in the form of injectables in the next five to ten years, then more life-saving medicines will be…
Despite global economic challenges, [India's pharmaceutical sector] has demonstrated robustness... We are determined to leverage this momentum
India, to me, has always been an intriguing puzzle, and if you can decipher it, it becomes a goldmine of opportunities
The nation's resilience in the face of global supply disruptions reflects its growing importance in the global landscape
Our ambition is to become a renowned, focused, and innovative player in oncology by targeting difficult and hard-to-treat cancers and to ensure patients benefit from our…
We already have a manufacturing plant for APIs and are committed to building a new formulation plant and expanding our existing R&D setup to strengthen our…
Reliance Life Sciences envisions a future characterized by a diverse and extensive portfolio. This involves not only a variety of product streams but also depth in…
The paradigm shift India needs is to transition from being the "pharmacy of the world" to actively engaging in pharmaceutical discoveries. This shift is the central…
As a result [of the NCG's comprehensive negotiation process with pharma companies], we secured remarkable discounts ranging from 23 percent to an incredible 99 percent off…
